OR WAIT null SECS
Larry Bellot, PhD, is scientific advisor, Cell and Gene Therapy, at Charles River Laboratories.
November 02, 2023
A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.